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Editorial
I would like to announce the first issue of “Nuclear Medicine 
Review” in 2019. The first chapter consists of six original articles. 
It opens with an article written by Polish colleagues who con-
firm that somatostatin receptor scintigraphy (SRS) with 99mTc 
HYNIC-TOC in SPECT or SPECT/CT techniques is an excellent tool 
for detection of primary neuroendocrine neoplasms G1/G2, as-
sessment of the clinical stage of disease and follow up after treat-
ment. The second article — by Greek researchers — shows that 
rheumatoid arthritis patients with atypical cardiac complaints are 
at higher risk of cardiovascular disease. Then, there are two 
papers from Poland. The first one indicates that PET/CT imag-
ing with 18F-fluoroethyl-L-tyrosine seems to have an additional 
value in the detection of recurring brain tumors and may be 
helpful in advanced radiation therapy planning. The second one 
shows that positive scintigraphy result depends on parathyroid 
histopathology and gland volume and does not depend on the 
presence of oxyphil cells. 
From Egypt, we received a paper concluding that 18F-FDG-PET/CT 
is a useful tool for disease extent evaluation of pediatric Lympho-
blastic Lymphoma. It could provide a diagnostic hint for BM involve-
ment. 18F-FDG-PET/CT done after induction therapy has a good 
negative predictive value with higher specificity than CT alone, but 
is not an indication for treatment intensification due to false positive 
results. The next article is from Poland again. The authors indicate 
that the problem with heart mispositioning during imaging on the 
cadmium-zinc-telluride (CZT) camera affects less than 1% of all 
performed studies and morbid obesity is not a contraindication 
to perform myocardial perfusion scintigraphy with the use of such 
a camera.
The Clinical Vignette section includes four very interesting case 
presentations sent by our colleagues from the United Kingdom, 
Turkey, Iran and Poland.
At the end of my letter I would like to wish all of you, dear friends, 
a Happy New Year!
Yours faithfully,
Grzegorz Kamiński
Editor-in-Chief 
Nuclear Medicine Review
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